25 KB
Mar 20, 2025, 8:06 PM UTC
The Department of Veterans Affairs, through Network Contracting Office 16, announces a Notice of Intent to award a Sole Source contract to Cardinal Health 414, LLC for the provision of Cu-64 Dotatate. This contract will be a Firm-Fixed-Price Indefinite Delivery Indefinite Quantity (IDIQ) with a base year and four one-year ordering periods, aimed at supporting the Central Arkansas Veterans Health Care System (CAVHS). The procurement, falling under NAICS code 325412, is authorized under Federal Acquisition Regulation (FAR) Parts 12 and 13.5, allowing for solicitation from a single source. Although competitive quotes are not being requested, interested parties have the opportunity to submit a letter demonstrating their qualifications to fulfill the contract requirements by April 4, 2025. The government emphasizes that those wishing to contest the sole sourcing must present substantial evidence to warrant competition. All correspondence should be directed to the designated Contracting Officer via email, with a clear subject line reference. Late submissions are discouraged, and any determination regarding competitive procurement rests solely with the Government.
87 KB
Mar 20, 2025, 8:06 PM UTC
The Central Arkansas Veterans Healthcare System (CAVHS) is issuing a request for proposals (RFP) for the provision of Cu-64 Dotatate radiopharmaceuticals for PET CT imaging. Due to regulatory requirements and the need for quick delivery, CAVHS requires a contractor to deliver pre-filled unit doses, with routine orders needing to be delivered by 6:30 a.m. and urgent requests within one hour. The contract is a Firm-Fixed-Price Indefinite Delivery Indefinite Quantity type and will operate 24/7, including holidays.
The contractor must ensure all deliveries follow required safety protocols for radioactive materials and that the personnel involved are properly trained and credentialed. Additional responsibilities include proper handling and confidentiality of patient samples, maintaining regulatory compliance, and providing evidence of FDA approval for the products delivered.
The document outlines a governance framework that emphasizes accountability for delays and establishes confidentiality rules to protect the government's interests. Overall, this SOW serves to ensure that CAVHS can efficiently and safely administer nuclear medicine procedures while adhering to regulatory standards.